Diagnosis and management of valvular aortic stenosis

Clinical Medicine Insights: Cardiology

Volumn 8, Issue , 2014, Pages 15-24

  Czarny, Matthew J ^a   Resar, Jon R ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Aortic stenosis therapy; Balloon aortic valvuloplasty; Surgical aortic valve replacement; Transcatheter aortic valve replacement; Valvular aortic stenosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGINA PECTORIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; AORTIC VALVE REPAIR; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONGENITAL HEART DISEASE; DEVICE THERAPY; DISEASE COURSE; FAINTNESS; HEART FAILURE; HIGH RISK PATIENT; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RHEUMATIC DISEASE; SURGICAL RISK; SYMPTOM; TRANSCATHETER AORTIC VALVE IMPLANTATION;

EID: 84941127989     PISSN: None     EISSN: 11795468     Source Type: Journal    
DOI: 10.4137/CMC.S15716     Document Type: Review

References (61)

1. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142-7.
2. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol. 1997;29:630-4.
3. Rajamannan NM, Evans FJ, Aikawa E, et al. Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease - 2011 update. Circulation. 2011;124:1783-91.
4. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol. 2012;60:1854-63.
5. Leopold JA. Cellular mechanisms of aortic valve calcification. Circ Cardiovasc Interv. 2012;5:605-14.
6. Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv. 2008;1:74-81.
7. Katz R, Wong ND, Kronmal R, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation. 2006;113:2113-9.
8. Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation. 2003;108:1804-8.
9. Thanassoulis G, Campbell CY, Owens DS, et al. Genetic associations with val­vular calcification and aortic stenosis. N Engl J Med. 2013;368:503-12.
10. Ngo DT, Sverdlov AL, Willoughby SR, et al. Determinants of occurrence of aortic sclerosis in an aging population. JACC Cardiovasc Imaging. 2009;2:919-27.
11. Owens DS, Otto CM. Is it time for a new paradigm in calcific aortic valve dis­ease? JACC Cardiovasc Imaging. 2009;2:928-30.
12. Miller JD, Chu Y, Brooks RM, Richenbacher WE, Pena-Silva R, Heistad DD. Dysregulation of antioxidant mechanisms contributes to increased oxi­dative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol. 2008;52:843-50.
13. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intesive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389-97.
14. Rossebø AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with sim­vastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343-56.
15. Arsenault BJ, Boekholdt SM, Mora S, et al. Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL). Am J Cardiol. 2014;113:1378-82.
16. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of lipid lowering with rosu­vastatin on progression of aortic stenosis: results of the Aortic Stenosis Progres­sion Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121:306-14.
17. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270-4.
18. Ellis SG, Dushman-Ellis S, Luke MM, et al. Pilot candidate gene analysis of patients $60 years old with aortic stenosis involving a tricuspid aortic valve. Am J Cardiol. 2012;110:88-92.
19. Bosse Y, Mathieu P, Pibarot P. Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis. J Am Coll Cardiol. 2008;51:1327-36.
20. Gaudreault N, Ducharme V, Lamontagne M, et al. Replication of genetic asso­ciation studies in aortic stenosis in adults. Am J Cardiol. 2011;108:1305-10.
21. Zhao W, Wang J, Shen J, et al. A nonsense variation p.Arg325X in the vascular endothelial growth factor-A gene may be associated with congenital tricuspid aortic valve stenosis. Cardiol Young. 2012;22:316-22.
22. Braverman AC, Guven H, Beardslee MA, Makan M, Kates AM, Moon MR. The bicuspid aortic valve. Curr Probl Cardiol. 2005;30:470-522.
23. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tri­cuspid aortic valves in adults having isolated aortic valve replacement for aor­tic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111:920-5.
24. Turri M, Thiene G, Bortolotti U, Milano A, Mazzucco A, Gallucci V. Surgical pathology of aortic valve disease. A study based on 602 specimens. Eur J Cardiothorac Surg. 1990;4:556-60.
25. Subramanian R, Olson LJ, Edwards WD. Surgical pathology of pure aortic stenosis: a study of 374 cases. Mayo Clin Proc. 1984;59:683-90.
26. Roberts WC, Vowels TJ, Filardo G, Ko JM, Mathur RP, Shirani J. Natural history of unoperated aortic stenosis during a 50-year period of cardiac valve replacement. Am J Cardiol. 2013;112:541-53.
27. Ward C. Clinical significance of the bicuspid aortic valve. Heart. 2000;83:81-5.
28. Ross J, Braunwald E. Aortic stenosis. Circulation. 1968;38(1 Suppl):61-7.
29. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr. 2009;10:1-25.
30. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. http://circ.ahajournals.org/content/early/2014/02/27/CIR.0000000000000031.citation.
31. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I. Am Heart J. 1951;41:1-29.
32. deFilippi CR, Willett DL, Brickner E, et al. Usefulness of dobutamine echocar­diography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol. 1995;75:191-4.
33. Pibarot P, Dumesnil JG. Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. J Am Coll Cardiol. 2012;60:1845-53.
34. Mohty D, Magne J, Deltreuil M, et al. Outcome and impact of surgery in paradoxical low-flow, low-gradient severe aortic stenosis and preserved left ventricular ejection fraction: a cardiac catheterization study. Circulation. 2013;128:S235-42.
35. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associ­ated with higher afterload and reduced survival. Circulation. 2007;115:2856-64.
36. Lester SJ, Heilbron B, Gin K, Dodek A, Jue J. The natural history and rate of progression of aortic stenosis. Chest. 1998;113:1109-14.
37. Chizner MA, Pearle DL, deLeon AC. The natural history of aortic stenosis in adults. Am Heart J. 1980;99:419-24.
38. Frank S, Johnson AE, Ross J. Natural history of valvular aortic stenosis. Br Heart J. 1973;35:41-6.
39. Eleid MF, Nishimura RA, Sorajja P, Borlaug BA. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction. Circulation. 2013;128:1349-53.
40. Khot UN, Novaro GM, Popović ZB, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med. 2003;348:1756-63.
41. Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circula­tion. 1994;89:642-50.
42. Otto CM, Bonow RO. Valvular heart disease. In: Bonow RO, Mann DL, Zipes DP, Libby P eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 9 ed. Philadelphia, PA: Elsevier Saunders; 2012:1468-539.
43. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105-10.
44. Goldberg JB, DeSimone JP, Kramer RS, et al. Impact of preoperative left ventricular ejection fraction on long-term survival after aortic valve replacement for aortic stenosis. Circ Cardiovasc Qual Outcomes. 2013;6:35-41.
45. Levy F, Laurent M, Monin JL, et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol. 2008;51:1466-72.
46. Monin JL, Quéré JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108:319-24.
47. Tribouilloy C, Lévy F, Rusinaru D, et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobu­tamine stress echocardiography. J Am Coll Cardiol. 2009;53:1865-73.
48. Clavel MA, Fuchs C, Burwash IG, et al. Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS study. Circula­tion. 2008;118:S234-42.
49. Nishimura RA, Grantham JA, Connolly HM, Schaff HV, Higano ST, Holmes DR. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation. 2002;106:809-13.
50. Quere JP, Monin JL, Levy F, et al. Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation. 2006;113:1738-44.
51. Ozkan A, Hachamovitch R, Kapadia SR, Tuzcu EM, Marwick TH. Impact of aortic valve replacement on outcome of symptomatic patients with severe aortic stenosis with low gradient and preserved left ventricular ejection fraction. Circu­lation. 2013;128:622-31.
52. Tarantini G, Covolo E, Razzolini R, et al. Valve replacement for severe aortic stenosis with low transvalvular gradient and left ventricular ejection fraction exceeding 0.50. Ann Thorac Surg. 2011;91:1808-15.
53. Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Sur­geons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856-65.
54. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implanta­tion for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607.
55. Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replace­ment for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696-704.
56. Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972-81.
57. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98.
58. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcath­eter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-95.
59. Thourani V. Three-year outcomes after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis. [Powerpoint pre­sentation]. 2013. Available at: http://clinicaltrialresults.org/Slides/ACC2013/Thourani_PARTNERCohortA_ACC2013.ppt. Accessed April 9, 2014.
60. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replace­ment with a self-expanding prosthesis. N Engl J Med. 2014;370:1790-8.
61. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replace­ment: the CHOICE randomized clinical trial. JAMA. 2014;311:1503-14.